1. Estimating the Maximum Safe Starting Dose for First-in-Human Clinical Trials Beatrice Setnik, Ph.D. Research Scientist February 12, 2007 2. Overview Introduction Selecting…

1. Intensity-Modulated Radiotherapy and Inverse Planning C-M Charlie Ma, Ph.D. Department of Radiation Oncology Fox Chase Cancer CenterPhiladelphia, PA 19111, USA 2. Outline…

1. PET/CTingynecologiccancer Anne Kiil Berthelsen, PET & Cyclotron Unit, Dept of Radiation Oncology Rigshospitalet,Copenhagen University Hospital, Denmark 2. 1PET scanner2PET/CT…

1. General Principles and Practical Pointsin Target Delineation: Esophageal CaYong Chan Ahn, MD, PhDDept of Radiation OncologySamsung Medical CenterSungkyunkwan University…

1. TSX:ONC NASDAQ:ONCYInvestor PresentationJanuary 2010 2. Forward Looking Statements Today’s presentation contains certain forward looking statements relating to the company’s…

1. EVOVLE Trial Sandeep G Huilgol 2. • Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis • Dr. Glenn M. Chertow et al N Engl J Med 2012;367:2482-94.…

1. a new class of non-opioid analgesic in Phase 3WEX Pharmaceuticals Inc.Bin Huang, President & CEOApril 2010 2. Forward looking StatementThis presentation contains forward-looking…

1. Clinical Trial Design Considerations for Therapeutic Cancer Vaccines Richard Simon, D.Sc. Chief, Biometric Research Branch, NCI http://linus.nci.nih.gov/brb 2. Why focus…

ASH 2014 UPDATE ASH 2014 UPDATE DR. RAJKUMAR M.D., D.M CONSULTANT MEDICAL ONCOLOGIST GURU CANCER CENTER OVERVIEW CHRONIC MYELOID LEUKEMIA MULTIPLE MYELOMA CHRONIC LYMPHOCYTIC…

1. - Large patient cohort prospective study with more than 500 patients and more than 5 years follow up have shown that CyberKnife is equally effective as long coures RT…